Health News

It was barely noon on Thursday when the metal doors of the mortuary at a hospital in south New Delhi swung open and staff in white coveralls rolled out a stretcher. Mourning relatives looked on, as a body bag was loaded into an ambulance and taken away to a cemetery.

Cancer patients with COVID-19 who were treated with a drug combination promoted by U.S. President Donald Trump to counter the coronavirus were three times more likely to die within 30 days than those who got either drug alone, U.S. researchers reported on Thursday.

AstraZeneca's top-selling drug Tagrisso has been shown to hold back a certain type of lung cancer when diagnosed at an early stage, the British drugmaker said on Thursday, potentially adding billions to its sales potential.

The number of coronavirus infections in France jumped on the same day the government announced an easing of lockdown rules, but the increase reflected the inclusion of new data rather than a rise in daily infections, the Health Ministry said.

Doctors in hospitals across the Chilean capital Santiago said on Wednesday beds are fast running short as new coronavirus cases spike across the city, forcing urgent care wards to make tough decisions with patients flooding the system.

The novel coronavirus has killed more than 100,000 people in the United States, according to a Reuters tally on Wednesday, even as the slowdown in deaths encouraged businesses to reopen and Americans to emerge from more than two months of lockdowns.

(This May 27 story has been refiled to add extension of stay-at-home order through June 12 in Michigan entry)

Spain's Valencia region will progress to the next phase of a gradual exit from one of Europe's strictest lockdowns, Health Minister Salvador Illa said on Thursday, as the country's coronavirus death toll rose by just one for the second straight day to 27,119.

France's coronavirus death toll rose by less than a 100 for the sixth day running on Tuesday, despite nursing home data being included again, raising hopes that the worst of the pandemic is over for the country.

France will allow restaurants, bars and cafes to reopen from June 2, though with more restrictions in Paris than elsewhere, Prime Minister Edouard Philippe said on Thursday as he announced the next phase in easing the country's coronavirus lockdown.

CVS Health Corp and unmanned vehicle delivery Nuro in June will start testing a service that drops prescriptions and other essentials free of charge to some customers in the Houston area, the companies said on Thursday.

A university in Germany has suspended a clinical study using the anti-malaria drug hydroxychloroquine for COVID-19, Spiegel Online reported on Thursday, after the World Health Organisation decided this week to pause a large trial over safety concerns.

Members of a Bolivian orchestra featuring traditional flutes and pipes hope to return home next week after being stranded in the grounds of a German castle for about 80 days due to the coronavirus epidemic.

Quest Diagnostics said on Thursday it received emergency use authorization (EUA) for its self-collection COVID-19 test kit from the U.S. Food and Drug Administration, sending its shares up 3%.

AstraZeneca has partnered with British cell therapy company Oxford Biomedica to make its experimental COVID-19 vaccine as the drugmaker looks to bolster its manufacturing capacity to produce one billion doses.

Papille purrs contentedly as her owner rubs the back of her head, her coat glossy and her eyes a piercing green - back to her old affection-seeking self after recovering from COVID-19.

Egypt registered 1,127 new coronavirus cases and 29 deaths, the health ministry said on Thursday, the highest daily increase.

The French government's contact-tracing app to curb the new coronavirus outbreak spread will be available from June 2, Prime Minister Edouard Philippe told a news conference on Thursday.

Spain said its coronavirus death toll reached 27,119 on Thursday, rising by just one for the second day in a row as authorities fine-tune a new way of logging cases and deaths.

Novartis re-entered vaccine making on Thursday, inking a manufacturing deal with a U.S. team whose COVID-19 candidate relies on technology similar to that of the Swiss drugmaker's $2.1 million-per-patient gene therapy, Zolgensma.